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Abstract
Purpose Intermittent energy restriction commonly refers to ad libitum energy intake punctuated with 24 h periods of severe 
energy restriction. This can improve markers of metabolic health but the effects on bone metabolism are unknown. This study 
assessed how 24 h severe energy restriction and subsequent refeeding affected markers of bone turnover.
Methods In a randomised order, 16 lean men and women completed 2, 48 h trials over 3 days. On day 1, participants con-
sumed a 24 h diet providing 100% [EB: 9.27 (1.43) MJ] or 25% [ER: 2.33 (0.34) MJ] of estimated energy requirements. On 
day 2, participants consumed a standardised breakfast (08:00), followed by an ad libitum lunch (12:00) and dinner (19:30). 
Participants then fasted overnight, returning on day 3. Plasma concentrations of C-terminal telopeptide of type I collagen 
(CTX), procollagen type 1 N-terminal propeptide (P1NP) and parathyroid hormone (PTH) were assessed as indices of bone 
metabolism after an overnight fast on days 1–3, and for 4 h after breakfast on day 2.
Results There were no differences between trials in fasting concentrations of CTX, P1NP or PTH on days 1–3 (P > 0.512). 
During both trials, consuming breakfast reduced CTX between 1 and 4 h (P < 0.001) and PTH between 1 and 2 h (P < 0.05), 
but did not affect P1NP (P = 0.773) Postprandial responses for CTX (P = 0.157), P1NP (P = 0.148) and PTH (P = 0.575) 
were not different between trials. Ad libitum energy intake on day 2 was greater on ER [12.62 (2.46) MJ] than EB [11.91 
(2.49) MJ].
Conclusions Twenty-four hour severe energy restriction does not affect markers of bone metabolism.
Keywords Intermittent energy restriction · Intermittent fasting · Bone · Bone metabolism · Weight management
Introduction
Net energy balance over time will dictate changes in body 
mass, with a chronic positive energy balance increasing 
both tissue mass and the risk of several chronic diseases 
[1]. For most people, weight gain tends to occur during 
early to middle adulthood (18–49 years of age), with modest 
yearly weight increments eventually leading to a substantial 
excess of adipose tissue and increased risk of obesity-related 
chronic diseases [2]. This indicates strategies to help facili-
tate attaining and/or sustaining a healthy proportion of body 
fat are required.
Imposing a daily limit on energy intake, such as reduc-
ing habitual energy intake by 20–50%, is a commonly used 
method of achieving a healthy weight [3]. This method 
does not, however, appear to be effective for long-term 
maintenance of a healthy weight in most people [4], with 
the requirement for daily adherence a likely barrier to suc-
cess [5]. One alternative method is intermittent energy 
restriction, which nominally involves alternating between 
periods of severely reduced energy intake (by ~ 75%) with 
periods of adequate or ad libitum energy intake [6]. Inter-
mittent energy restriction can achieve similar weight loss 
and reduction in risk markers of obesity-related diseases 
compared to continuous energy restriction [7], suggesting 
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this may be a viable alternative weight management 
strategy.
It is unknown whether severe energy restriction and 
the resultant acute perturbation of energy balance influ-
ences bone remodelling (i.e. osteoclastic bone resorption 
and osteoblastic bone formation). Bone mineral density 
is dictated by the balance between bone formation and 
resorption that occurs over time, which is a reflection of 
the physiological and mechanical environment [8]. Energy 
restriction is a risk factor for stress fracture incidence [9, 
10], bone metabolism is markedly disrupted by 3–5 days 
of energy restriction (i.e. 10–30 kcal kg LBM−1 day−1), as 
evidenced by reductions in plasma markers of bone forma-
tion but without a corresponding decrease in bone resorp-
tion markers [11, 12]. Whilst these studies clearly demon-
strate the potential for sustained moderate–severe energy 
restriction to impair bone health, typically, intermittent 
energy restriction involves shorter periods (1–2 days) of 
limited energy intake (~ 10–15 kcal kg LBM−1 day−1) but 
interspersed with refeeding periods [6]. Such cyclic energy 
restriction and replacement over serial days, therefore, rep-
resent a different model for which the daily kinetics of 
bone metabolism have never been assessed. One recent 
study has reported that the accumulated effect of 6 months 
of alternating daily between 25 and 125% of energy 
requirements did not alter post-absorptive markers of bone 
resorption (CTX, osteocalcin) or formation (bone alkaline 
phosphatase) at follow-up relative to standard continuous 
energy restriction or control [13]. However, this study 
employed a self-selected diet in the final 3 months of the 
intervention, with food diaries revealing only ~ 500 kcal 
difference between ‘fed’ and ‘fasting’ days in the alter-
nate-day fasting condition. As such, the acute day-to-day 
variance in bone metabolism between the fasted days and 
subsequent refeeding days remains unknown.
Feeding is an essential stimulus for bone tissue accre-
tion, as it causes an immediate postprandial reduction in 
markers of bone resorption and increases in markers of bone 
formation [14-16]. The majority of previous studies have 
assessed markers of bone metabolism in the fasted state, but 
the magnitude and duration of the response in bone meta-
bolic markers after food intake may have a critical impact 
on bone remodelling. Recent studies have observed that the 
effects of short-term (1–2 days) severe energy restriction 
(consuming 10–15 kcal kg LBM−1 day−1) are not readily 
apparent in the fasted-state, but become pronounced upon 
refeeding. When comparing severe energy restriction diets to 
energy balanced maintenance control diets, previous studies 
have shown alterations in postprandial glucose, insulin, fatty 
acids, glucagon-like peptide-1, peptide-P and ghrelin after 
24–48 h of severe energy restriction [17-20], with several of 
these hormones/substrates also postulated to influence bone 
remodelling [15].
To understand the efficacy and possible bone health 
effects of intermittent energy restriction diets, it is impor-
tant to determine how a short period of severe energy 
restriction affects markers of bone remodelling upon 
refeeding. This will elucidate how intermittent energy 
restriction might affect bone health. Accordingly, this 
experiment investigated how markers of bone turnover 
respond temporally to an acute episode of severe energy 
restriction and refeeding, compared to an energy balanced 
control trial. This study was performed in young, lean 
individuals to investigate the effect of this eating pattern 
as a means to prevent weight gain.
Methods
Participants
This is a secondary analysis of a study that compared 24 
h diets of 25% (ER) and 100% (EB) of estimated energy 
requirements (EER) on appetite regulation and energy 
intake [17]. This trial is registered at https ://www.clini 
caltr ials.gov.uk as NCT02696772. Eighteen men (n = 10) 
and women (n = 8) were recruited and provided written 
informed consent to take part in the original study. Two 
men were removed from this analysis due to issues with 
obtaining blood samples during 1 trial (Table 1). Partici-
pants were healthy, weight stable (self-reported) and rec-
reationally active (3–10 h week−1).
Study design
Height, mass and body fat percentage were determined 
during a 1-day preliminary trial. Participants then com-
pleted two 3-day experimental trials administered in a 
randomised, crossover, and counterbalanced order. Trials 
were separated by at least 14 days for men and by exactly 
one menstrual cycle for women, who were tested during 
the post-menstruation follicular phase (5–12 days after the 
onset of menstruation) [21].
Table 1  Participant baseline characteristics
Values are mean (1SD)
Male (n = 8) Female (n = 8) Combined (n = 16)
Age (years) 23 (2) 21 (2) 22 (2)
Weight (kg) 75.6 (6.6) 63.8 (8.6) 69.7 (9.6)
Height (m) 1.80 (0.04) 1.61 (0.05) 1.70 (0.11)
BMI (kg m−2) 23.4 (2.2) 24.5 (2.3) 24.0 (2.2)
Body fat (%) 14.3 (3.4) 27.3 (5.0) 20.8 (7.9)
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Protocol
During the 2 days immediately preceding the first experi-
mental trial, participants recorded dietary intake and habit-
ual physical activity, which was subsequently repeated in the 
2 days immediately preceding the second experimental trial. 
Alcohol consumption and moderate/vigorous exercise were 
not permitted during this time or during the experimental 
trials. For each trial, participants arrived at the laboratory at 
07:30 on three consecutive mornings having fasted at least 
10 h, and post-void nude body mass was measured.
On day 1, a blood sample was collected via venepuncture 
(− 24 h), after which (08:30) participants left the labora-
tory with a 24 h diet providing either 25% or 100% of EER 
(resting metabolic rate estimated from Mifflin et al. [22] 
multiplied by 1.4) and instructions on when to consume 
each item. During EB, 100% of EER [9.27 (1.43) MJ] was 
distributed into four meals: 20% (of total food energy on 
EB) at 08:00 (cereal, milk and orange juice), 30% at 12:00 
(white bread, chicken, mayonnaise, salad and cookies), 10% 
at 16:00 (yogurt and cereal bar), and 40% at 19:00 (pasta, 
chicken, Bolognese sauce, olive oil and cookies). During 
ER, 25% of EER [2.33 (0.34) MJ] was divided between two 
meals: 34% (of total food energy on ER) at 12:00 (chicken 
and salad) and 66% at 19:00 (pasta, chicken and Bolognese 
sauce), with a bolus of water consumed at 08:00 on ER, 
isovolume to the morning meal provided at 08:00 during 
EB. Additional water intake on both trials was prescribed 
at 35 mL kg−1 body mass [2516 (283) mL] and was evenly 
distributed throughout the day. Diets were tailored to par-
ticipants’ preferences. The ER diet was created by primar-
ily removing high-carbohydrate and high-fat foods from 
the EB diet to preserve protein content and ensure similar 
foods were provided on day 1 for both trials. Lean body 
mass (LBM) was derived from body mass and body fat 
percentages determined from skinfold measurements col-
lected at baseline [23]. It was estimated that the EB diet 
provided 40 (2) kcal kg LBM−1 and the ER diet provided 10 
(1) kcal kg LBM−1. Participants were asked to perform mini-
mal physical activity when outside the laboratory, including 
the strict avoidance of any structured exercise.
On day 2, participants arrived at 07:30, and remained in 
the laboratory until 20:00, with all food consumed in the 
laboratory. A fasted blood sample was collected (0 h; 08:00) 
from an indwelling cannula, after which participants con-
sumed a standardised breakfast consisting of cereal, semi-
skimmed milk, white bread, jam and butter, providing 25% 
of EER [2.44 (0.35) MJ; 93 (14) g carbohydrate; 16 (2) g 
protein; 15(2) g fat, 3 (0) g fibre]. Further blood samples 
were collected 1, 2, and 4 h after commencement of this 
meal. Participants were provided ad libitum lunch (12:00; 
4 h) and dinner (19:00; 11 h) meals, as well as a standard-
ised mid-afternoon snack [16:00; 8 h; 0.86 (0.12) MJ], as 
described previously [17]. Participants left the laboratory 
after dinner 20:00 (12 h), but were not permitted to consume 
any additional food or drink (other than plain water). Par-
ticipants returned to the laboratory at 07:30, the following 
morning (day 3) and a final blood sample was collected via 
venepuncture (08:00; 24 h; Fig. 1).
Blood sample collection and analysis
C-terminal telopeptide of type I collagen (CTX) and procol-
lagen type 1 N-terminal propeptide (P1NP) were selected 
as markers of bone resorption and formation, as recom-
mended by the International Osteoporosis Foundation and 
Fig. 1  Schematic representation of study design
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the International Federation of Clinical Chemistry [24]. 
Parathyroid hormone (PTH) was also measured as a marker 
of calcium metabolism. For each sample, blood was col-
lected from an antecubital vein after at least 30 min of supine 
rest, and was dispensed into pre-chilled tubes containing 
EDTA (1.75 mg mL−1). Plasma was separated by centri-
fuge (15 min; 1750g; 4 °C) and the supernatant was stored 
at − 20 °C for 24 h, before being transferred to − 80 °C for 
later analysis. Samples collected at − 24, 0, 1, 2, 4 and 24 
h were analysed for concentrations of total P1NP (Bioas-
say Technology Laboratory, Shanghai, China; CV ≤ 12.5%), 
CTX (Immunodiagnostic Systems, West Bolden, UK; 
CV ≤ 5.2%) and PTH (DiaMetra, Milan, Italy; CV ≤ 10.3%) 
by ELISA.
Statistical analysis
Data were analysed using SPSS 24.0 (SPSS Inc, Chicago, 
USA). All data were checked for normality using a Sha-
piro–Wilk test. Repeated measures ANOVA was used to 
evaluate main effects of time, trial and time-by-trial inter-
actions, followed where necessary, by Holm–Bonferroni 
adjusted post hoc paired t tests (normally distributed data) 
or Wilcoxon signed-ranks tests (non-normally distributed 
data). Total area under the curve (AUC) was calculated in 
response to the standard breakfast (0–4 h) using the trap-
ezoidal method and were analysed using a t test or Wilcoxon 
signed-ranks test, as appropriate. Sex was also entered as 
a between-participant factor in repeated measures to test 
for sex-by-time-by-trial and sex-by-trial interaction effects. 
Data sets were determined to be significantly different when 
P < 0.05. Data are presented as mean (1SD) unless stated 
otherwise.
Results
Body mass
There were main sex-by time (P < 0.05) and sex-by-time-by-
trial (P < 0.05) effects, whereby body mass loss during ER 
between day 1 and day 2 was greater in males than females 
(P < 0.001). However, these differences were due to the 
larger body mass of males compared to females, as when 
presented as a percentage change in body mass, no differ-
ences were noted (P = 0.524) and, therefore, male and female 
data are presented together. There were time (P < 0.001) and 
interaction (P < 0.001) effects for body mass. Body mass 
was not different between trials on day 1 (P = 0.059) or day 
3 (P > 1.00), but was lower during ER on day 2 (P < 0.01). 
Body mass decreased from day 1 to day 2 during both trials, 
but to a greater extent during ER (P < 0.001; Table 2).
CTX and P1NP
There were no sex-by-time-by-trial effects for CTX 
(P = 0.188) or P1NP (P = 0.426), so male and female data 
are presented together. There were no differences between 
trials at − 24 h (baseline) in plasma CTX (P = 0.532) or 
P1NP (P = 0.548) concentrations.
There was a time (P < 0.001), but no trial (P = 0.489) 
or interaction (P = 0.157) effects for CTX. Compared to 
baseline, plasma CTX concentrations were not different 
at 0 h (P = 0.512). Plasma CTX concentrations decreased 
after consuming breakfast, and were lower than baseline 
between 1 and 4 h, (P < 0.001) but were not different at 24 
h (P = 0.110). There was no difference in postprandial AUC 
between trials for CTX (P = 0.916; Fig. 2a).
There were no time (P = 0.773), trial (P = 0.584) or inter-
action (P = 0.148) effects for P1NP (Fig. 2b). There was no 
difference in postprandial AUC between trials for P1NP 
(P = 0.661; Fig. 2b).
PTH
There were no sex-by-time-by-trial (P = 0.471) effects for 
PTH, so male and female data are presented together. There 
were no differences between trials in fasting plasma PTH 
(P = 0.573) concentrations at − 24 h (baseline).
There was a time effect (P < 0.001), but no trial 
(P = 0.566) or interaction (P = 0.575) effects for PTH. 
Table 2  Morning body mass measurements during each day of each experimental trial
Values are mean (1SD)
EB energy balance trial, ER energy restriction trial
† Significant difference to EB at corresponding time point
*Significant difference to − 24 h during the same trial (P < 0.05)
Energy balance (EB) Energy restriction (ER)
Day 1 (− 24 h) Day 2 (0 h) Day 3 (24 h) Day 1 (− 24 h) Day 2 (0 h) Day 3 (24 h)
Body mass (kg) 69.2 (9.6) 68.9 (9.6)* 68.9 (9.6)* 69.5 (9.8) 68.4 (9.5)†,* 68.9 (9.7)*
Δ from day 1 (kg) – − 0.3 (0.3) − 0.3 (0.5) – − 1.1 (0.4)† − 0.6 (0.4)†
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Compared to baseline, plasma PTH concentrations were 
similar at 0  h (P = 1.00). Plasma PTH concentrations 
decreased after consuming breakfast and were lower than 
baseline at 1 h (P < 0.001) and 2 h (P < 0.05), but not 4 h 
or 24 h (P = 1.00). There was no difference in postprandial 
AUC between trials for PTH (P = 0.678; Fig. 2c).
Energy intake
There was a between-participant main effect of sex, 
with ad libitum energy intake greater in males compared 
to females (P < 0.001), but there were no sex-by-trial 
(P = 0.614) or sex-by-time-by-trial (P = 0.086) interaction 
effects for energy intake, so male and female data are pre-
sented together.
Energy provided in the pre-prepared diets on day 1 was 
6.94 (1.00) MJ lower on ER compared to EB (Table 2). On 
day 2, total ad libitum energy intake (i.e. lunch and dinner) 
was greater during ER compared to EB [EB: 8.62 (2.14) MJ; 
ER: 9.33 (2.14) MJ; P < 0.05]. The greater energy intake on 
day 2 [0.71 (1.27) MJ] was sufficient to replace ~ 11% of the 
energy deficit created on day 1 (Table 3).
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Fig. 2  Top panel shows C-terminal telopeptide of type I collagen 
(CTX) (a), middle panel shows procollagen N-terminal propeptide 
(P1NP) (b) and bottom panel shows parathyroid hormone (PTH) 
(c). From left to right, concentrations at each time-point for all par-
ticipants (n = 16), concentrations at each time-point for male (n = 8) 
and female (n = 8) participants, total area under the curve for all par-
ticipants after consuming the standardised breakfast (0–4  h; 08:00–
12:00). Hatched box indicates when breakfast was consumed. Data 
are mean with error bars representing standard error of the mean. 
Asterisk indicates the value is significantly different to baseline (− 24 
h)
 European Journal of Nutrition
1 3
Discussion
The present study shows that an acute episode of severe 
energy restriction has no effect on markers of bone metabo-
lism in the fasted state, or for 4 h after consuming a high-
carbohydrate breakfast. Although short periods of severe 
energy restriction (such as intermittent fasting) might not, 
therefore, have a deleterious effect on bone health, longer 
term studies utilising radiological scanning to elicit a more 
direct assessment of bone health are warranted.
This study assessed the effect of an acute 24 h period 
of severe energy restriction on markers of bone formation 
and resorption in fasted and postprandial states, finding 
that a diet providing ~ 10 kcal kg LBM−1 had no immediate 
effects on markers of bone metabolism. In the fasted state, 
studies of longer periods of continuous energy restriction 
have observed a dose–response decrease in markers of bone 
formation (P1CP) when energy availability was restricted 
to 10, 20 or 30 kcal kg LBM−1 day−1 for 5 days, but N-ter-
minal telopeptide (NTX; a marker of bone resorption) was 
only increased in the 10 kcal kg LBM−1 day−1 condition 
[12]. Similarly, Papageorgiou et al. [11] showed a decrease 
in a marker of bone formation (P1NP), but no change in a 
marker of bone resorption (CTX) after restricting energy 
availability to 15 kcal kg LBM−1 day−1 for 3 days. In com-
bination with the current study, these studies suggest that 
the length of energy restriction or the total energy deficit 
created is important when considering the effect on bone 
formation and resorption. It may also be that a threshold in 
duration or magnitude exists, or a combination of these two 
factors, before energy restriction elicits a deleterious effect 
on bone metabolism, although this remains to be systemati-
cally investigated.
The current study also found there was no effect on mark-
ers of bone metabolism to feeding the following day. This is 
important as feeding is critical to the bone remodelling pro-
cess [8]. As the current study only assessed the postprandial 
response to the first meal consumed after energy restriction, 
it is possible that delayed changes occurring in the subse-
quent hours or days were not captured. Studies that assess 
bone metabolism in response to multiple meals over multiple 
days would be required to elucidate this. The current data 
indicate that diets involving short periods of severe energy 
restriction alternated with longer periods of adequate energy 
intake might not detrimentally affect bone health. Whilst 
further research is required to determine the chronic effects, 
intermittent energy restriction diets may aid bone health to a 
greater extent than continuous energy restriction diets, which 
have consistently been shown to reduce bone health [25].
Consistent with the results of the current study, Barnosky 
et al. [13] found markers of bone metabolism in the fasted 
state were unchanged after 6-month alternate-day modified 
fasting or continuous energy restriction. Although surpris-
ingly, Barnosky et al. [13] also reported no change in bone 
mineral content or BMD, in any condition, despite partici-
pants losing approximately 8% body mass. These measure-
ments of bone remodelling were a secondary analysis of a 
larger study [26], which also found that when participants 
were permitted to self-select their diet, the disparity between 
‘fasting’ and ‘fed’ days was less than 500 kcal by study end-
point. It is, therefore, debatable whether this study truly 
assessed the effects of intermittent severe energy restriction 
dieting. Nevertheless, weight-loss achieved via continuous 
energy restriction has been consistently shown to lead to 
reduced BMD [25]. Issues with dual-energy X-ray absorp-
tiometry (DXA) in participants losing weight [8, 27], as 
Table 3  Total and relative energy and macronutrient intake during each day of the experimental trial
Values are mean (1SD) and are presented in grams (g), grams per kilogram of body mass (g kg BM−1), megajoules (MJ) and kilojoules per kilo-
gram of body mass (kJ kg BM−1)
EB energy balance trial, ER energy restriction trial
† Significantly different from EB (P < 0.05)
Day 1 Day 2 Average
EB ER EB ER EB ER
Protein (g) 97 (15) 60 (9)† 93 (20) 97 (18) 95 (16) 78 (12)†
Protein (g kg BM−1) 1.39 (0.11) 0.87 (0.08)† 1.34 (0.26) 1.41 (0.21) 1.37 (0.17) 1.14 (0.13)†
Carbohydrate (g) 293 (44) 56 (8)† 402 (91) 419 (98) 347 (64) 237 (52)†
Carbohydrate (g kg BM−1) 4.21 (0.11) 0.81 (0.05)† 5.77 (1.11) 6.09 (1.19) 4.99 (0.70) 3.45 (0.61)†
Fat (g) 69 (10) 9 (1)† 90 (23) 99 (21)† 80 (15) 54 (11)†
Fat (g kg BM−1) 0.99 (0.06) 0.13 (0.01)† 1.30 (0.06) 1.46 (0.30)† 1.14 (0.16) 0.79 (0.15)†
Fibre (g) 11 (2) 3 (1)† 21 (5) 22 (5) 16 (3) 13 (3)†
Fibre (g kg BM−1) 0.16 (0.01) 0.05 (0.00)† 0.31 (0.06) 0.32 (0.06) 0.23 (0.04) 0.18 (0.03)†
Energy (MJ) 9.23 (1.34) 2.33 (0.34)† 11.91 (2.49) 12.62 (2.46)† 10.59 (1.83) 7.48 (1.36)†
Energy (kJ kg BM−1) 133 (9) 34 (2)† 171 (30) 184 (29)† 157 (19) 109 (15)†
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well as difficulty controlling exercise [28] and diet compo-
sition (e.g. calcium intake) [29], over a 6-month interven-
tion period involving 3-months of self-selected food intake, 
might help to explain why these results differ from other 
diet-induced weight-loss studies.
The present study is the first to report how bone meta-
bolic markers respond after energy restriction in the post-
prandial state, finding that 24 h of severe energy restriction 
did not affect markers of bone resorption or bone forma-
tion in response to feeding. Consuming a meal of individual 
or mixed macronutrient content causes a rapid suppres-
sion of bone resorption markers [14-16]. Feeding, there-
fore, acutely influences markers of bone metabolism, but 
whether this response is affected after a dietary interven-
tion is rarely considered. Given the importance of feeding 
to bone metabolism, an impaired postprandial bone meta-
bolic response could be indicative of a deleterious effect on 
BMD. Consistent with most acute studies, this study showed 
CTX (marker of bone resorption) was strongly suppressed 
after feeding, with no change in P1NP (marker of bone 
formation). Importantly, the postprandial bone metabolic 
response was similar, whether participants had consumed 
25% (~ 10 kcal kg LBM−1) or 100% (~ 40 kcal kg LBM−1) 
of their energy requirements the previous day, indicating 
that a single 24 h period of severe energy restriction does not 
interfere with the subsequent postprandial bone remodelling 
response. How bone metabolism responds during the energy 
restriction period itself remains unknown. It seems likely 
that energy restriction of this severity would have a negative 
impact on bone metabolism, but it would be interesting to 
explore in future studies what the net effect is of 24 h severe 
energy restriction and subsequent ad libitum refeeding on 
bone remodelling.
PTH is recognised as a key factor in bone remodelling, 
with elevated concentrations increasing bone turnover [30]. 
Results of the present study demonstrate that 24 h of severe 
energy restriction does not affect PTH concentrations, 
indicating that PTH does not change in response to acute 
perturbations in energy balance. Whilst no difference was 
shown in PTH, the original study on which this secondary 
analysis was performed showed that several factors associ-
ated with bone metabolism were affected by 24 h of severe 
energy restriction. After consuming a standardised meal, 
Clayton et al. [17] showed elevated plasma glucose, sup-
pressed plasma acylated ghrelin and a tendency (P = 0.06) 
for elevated plasma insulin concentrations, after 24 h severe 
energy restriction compared to 24 h of adequate energy 
intake. A similar study involving a short period of severe 
energy restriction (< 10% EER for 48 h) with subsequent 
refeeding similarly showed these changes, as well as elevated 
peptide P, glucagon-like peptide-1 and total ghrelin [18]. 
Despite several of these endocrine changes being linked to 
bone metabolism [15], no postprandial changes in markers 
of bone metabolism in response to acute energy restriction 
were observed in the current study.
Mechanistic evidence explaining the involvement of 
endocrine factors on bone remodelling is derived primarily 
from studies that have identified corresponding receptors 
expressed on osteoblasts and/or osteoclasts [31]. However, 
in vivo evidence showing a clear effect of these endocrine 
factors on bone metabolism is lacking. For example, diabetes 
and insulin resistance are associated with increased fracture 
risk [32], but glucose-clamp studies infusing insulin across 
the physiological range showed no change in bone forma-
tion or resorption, suggesting insulin per se does not directly 
impact bone metabolism [33]. The results of the current 
study indicate that insulin and other aforementioned endo-
crine factors are not involved in the immediate post-prandial 
bone metabolic response following severe energy restriction. 
However, the time-course response for changes in markers of 
bone metabolism is not fully established. Although no differ-
ences were noted in fasting concentrations on days 1 and 2, it 
is possible that the observed postprandial changes in associ-
ated endocrine factors precede changes in bone metabolism. 
Therefore, this might not have been captured by the current 
study. Studies with longer monitoring periods, for example, 
over multiple restriction-repletion cycles and in response 
to several meals, are required to fully establish whether an 
acute episode of energy restriction affects bone remodelling. 
In addition, future studies should aim to investigate the cause 
of altered bone metabolism through dietary manipulation, by 
assessing fluctuations in hormones (e.g. incretin hormones 
and those associated with bone regulatory pathways such as 
Wnt signalling) that have a suggested association with bone 
metabolism.
Alongside diet, exercise is considered to be important 
for achieving successful long-term weight management 
[34]. Weight-bearing exercise is typically considered to 
have an anabolic effect on bone initiated via an increase in 
bone loading [35]. However, the extent to which exercise 
increases BMD is likely to be, at least partially, mediated by 
energy availability. A recent study [36] showed that restrict-
ing energy intake after a morning high-intensity exercise 
session to ~ 10 kcal kg BM−1 resulted in greater concentra-
tions of CTX in comparison to consuming a diet provid-
ing ~ 52 kcal kg BM−1. This study also showed that energy 
provided specifically by carbohydrate, rather than overall 
energy availability was important in attenuating bone resorp-
tion after exercise. These results suggest the undertaking of 
exercise during intermittent energy restriction, particularly 
when implemented with carbohydrate restriction, may have 
a detrimental effect on bone metabolism.
Traditionally, intermittent fasting has been considered a 
means of achieving weight loss rather than weight mainte-
nance. It is unclear from the current study whether acute 
severe energy restriction would prompt a similar bone 
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metabolic response in an overweight or obese population. 
Due to relatively greater bone loading caused by carrying 
additional weight, it might be expected that bone turnover 
would be increased in obese individuals, causing the accrual 
of bone mass if the loading stimulus is of an appropriate 
magnitude [25]. In line with Hammond et al. [36], it could 
be speculated that reduced energy and/or carbohydrate 
intake in this population may impair optimal bone remodel-
ling leading to an increase in bone resorption. Future stud-
ies should aim to investigate the effects of severe energy 
restriction in overweight and obese individuals, as well as 
people at increased risk of fragility fracture, such as post-
menopausal women.
In conclusion, 24 h of severe energy restriction had no 
effect on markers of bone resorption or bone formation. 
The acute nature of the intervention may explain why bone 
metabolism was unchanged. This suggests that short-term 
severe energy restriction as a method of weight control 
might not negatively affect bone health, but further studies 
are required to determine how repeated episodes to severe 
energy restriction influence long-term bone accrual.
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